Regarded as an ‘excellent’ and ’incredibly hard working’ group, Herbert Smith Freehills LLP leverages its global presence to manage complex cross-border litigation and significant transactions involving R&D in the technology and life sciences areas. Practice leader Sebastian Moore is routinely counted on by sizeable pharmaceutical companies for assistance with patent litigation. The technically capable Andrew Moir is highly active in the UK patent litigation sphere and demonstrates particular proficiencies in the technology arena, while Jonathan Turnbull frequently handles matters pertaining to innovation and collaboration, leveraging his expansive scientific background in chemistry, biochemistry, genetics, and molecular biology. Andrew Wells is an expert in European and global patent strategy and Emily Bottle is a strong choice for pharma and diagnostics companies. Emma Sherratt is another name to note. Peter Dalton re-joined from Stephenson Harwood in November 2023.
Testimonials
Collated independently by Legal 500 research team.
‘Incredibly hard working, great attention to detail, very knowledgeable.’
‘Jonathan Turnbull has excellent client care, is a great team leader, and is very involved in the detail.'
‘Wonderful cross practice and offices collaboration. I have great confidence that the entire team is coordinated, collaborative and working to serve the client's best interest, no matter what office and the practice group. A single, unified force dedicated to serving the client.'
‘They are excellent, easy to work with and really adds value to everything they do.’
‘Emily Bottle, Priyanka Madan and Sebastian Moore are all excellent.'
‘Sebastian Moore is very client friendly, responsive and easy to work with.’
'Bringing the clout of an international major full-service firm, HSF offers fantastic service to clients with the most important worldwide intellectual property disputes, especially in the fields of electronics, computing and related high-tech.'
'Andrew Wells shows exceptional ability and strategic supremacy.'
Key clients
- Biogen
- R2 Semiconductor
- Seoul Semiconductor
- Gilead Sciences
- Takeda
- Sky
- Roche
- AbbVie
- British American Tobacco
- General Mills
- Sanofi
Work highlights
- Advising Sanofi in a number of key jurisdictions – including the UK, France, Germany, and Italy, in developing litigation strategy for its multiple sclerosis drug, Aubagio®.
- Representing R2 Semiconductor in UK High Court proceedings enforcing its patent against Intel relating to on-chip voltage regulators comprising switched mode regulator circuitry and voltage spike protection circuitry.
- Representing Millennium Pharmaceuticals and its licensee Johnson & Johnson in the pan-European defence of Velcade's market exclusivity (bortezomib), a first in class drug used to treat multiple myeloma and mantle cell lymphoma.
Practice head
The lawyer(s) leading their teams.
Sebastian Moore